Literature DB >> 23105701

Role of Helicobacter pylori and hyperammonemia in subclinical hepatic encephalopathy in cirrhosis of liver.

C Rekha1, Srinivasa Phanidhar, A Vidya Sagar, A Revathi, W A Asra.   

Abstract

In a prospective study of 47 patients of subclinical hepatic encephalopathy in cirrhosis of liver, aged between 23 and 60 years, 49% showed Helicobacter pylori positivity by rapid urease test. The baseline characters of patients (mean age, serum creatinine, sereum albumin, serum bilirubin, prothrombin time) were similar among patients with and without Helicobacter infection in all the patients. There was no statistically significant difference in blood ammonia levels in either group of patients. Blood ammonia values showed good correlation with the functional state of liver function but they did not show statistically significant difference between two groups of patients in any of Child Pugh classes. It is concluded that Helicobacter pylori does not contribute significantly to blood ammonia levels and the severity of hepatic encephalopathy.

Entities:  

Keywords:  Cirrhosis of liver; Helicobacter pylori; Hepatic encephalopathy; Hyperammonemia

Year:  2007        PMID: 23105701      PMCID: PMC3453803          DOI: 10.1007/BF02913332

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  13 in total

1.  Prospective comparison of commercially available rapid urease tests for the diagnosis of Helicobacter pylori.

Authors:  L Laine; D Lewin; W Naritoku; R Estrada; H Cohen
Journal:  Gastrointest Endosc       Date:  1996-11       Impact factor: 9.427

2.  Role of Helicobacter pylori infection in hyperammonemia and subclinical hepatic encephalopathy in cirrhosis of liver.

Authors:  D Kini; R Aggarwal; V A Saraswat; S R Naik
Journal:  Indian J Gastroenterol       Date:  2001 Nov-Dec

Review 3.  Pathophysiology of hepatic encephalopathy.

Authors:  S Schenker; A M Hoyumpa
Journal:  Hosp Pract (Off Ed)       Date:  1984-09

4.  Hyperammonaemia and Helicobacter pylori.

Authors:  S Ito; H Miyaji; T Azuma; Y Li; Y Ito; T Kato; Y Kohli; M Kuriyama
Journal:  Lancet       Date:  1995-07-08       Impact factor: 79.321

5.  Hyperammonaemia in cirrhosis and Helicobacter pylori infection.

Authors:  J N Plevris; R Morgenstern; P C Hayes; I A Bouchier
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321

6.  Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis.

Authors:  H Miyaji; S Ito; T Azuma; Y Ito; Y Yamazaki; Y Ohtaki; F Sato; M Hirai; M Kuriyama; Y Kohli
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

7.  Purification and characterization of urease from Helicobacter pylori.

Authors:  B E Dunn; G P Campbell; G I Perez-Perez; M J Blaser
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

8.  Changes in serum ammonia concentration in cirrhotic patients with Helicobacter pylori infection.

Authors:  J Si; Q Cao; M Gao; L Fang; G Qian; Y Wang
Journal:  Chin Med J (Engl)       Date:  2000-12       Impact factor: 2.628

9.  Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication.

Authors:  C Vásconez; J I Elizalde; J Llach; A Ginès; C de la Rosa; R M Fernández; A Mas; J Santamaría; J M Bordas; J M Piqué; J Terés
Journal:  J Hepatol       Date:  1999-02       Impact factor: 25.083

10.  Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection.

Authors:  B M Dasani; S H Sigal; C S Lieber
Journal:  Am J Gastroenterol       Date:  1998-05       Impact factor: 10.864

View more
  1 in total

1.  Helicobacter pylori infection among patients with liver cirrhosis.

Authors:  Joanna Pogorzelska; Magda Łapińska; Alicja Kalinowska; Tadeusz W Łapiński; Robert Flisiak
Journal:  Eur J Gastroenterol Hepatol       Date:  2017-10       Impact factor: 2.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.